Developing Treatment Trends and Patient Implications
A new generation of prostate cancer care is being shaped through major new developments underway including new drugs, imaging technology, molecular and genetic testings and more. An overview of these developing trends and the implications for patients will be presented.
A Groundbreaking research study on prostate cancer in African-American men has been launched and will be presented during the "clinical trials" session. RESPOND, a $26.5 million study is the largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men and was announced in July 2018.More about RESPOND.